Skip Nav Destination

Issue Archive

Select Year

Issue

Volume 21, Issue 6

November-December 2024

In this Issue

Clinical Trials Corner
Diffusion
Feature
Headlines from Washington
No Data Zone
President’s Column

Clinical Trials Corner

An Alternative to ‘Watch and Wait’ for Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma?

Brian T. Hill, MD, PhD

View Articletitled, An Alternative to ‘Watch and Wait’ for Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma?

Liquid Biopsy in Diffuse Large B-Cell Lymphoma

Elizabeth L. Courville, MD

View Articletitled, Liquid Biopsy in Diffuse Large B-Cell Lymphoma

Diffusion

Hemolysis Be Gone: Iptacopan’s Role in Paroxysmal Nocturnal Hemoglobinuria

Zoey I. Harris, MD,Surbhi Shah, MBBS, MD

View Articletitled, Hemolysis Be Gone: Iptacopan’s Role in Paroxysmal Nocturnal Hemoglobinuria

To Drive or Park the CAR: What Is the Best Option for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma?

Tycel Phillips, MD

View Articletitled, To Drive or Park the CAR: What Is the Best Option for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma?

Blinatumomab for B-ALL? Unraveling E1910 Trial Results for the Practicing Hematologist

Marlise R. Luskin, MD, MSCE,Lori Muffly, MD, MS

View Articletitled, Blinatumomab for B-ALL? Unraveling E1910 Trial Results for the Practicing Hematologist

DREAMMing of a Better Tomorrow: Belantamab-Based Triplet Therapy for Relapsed/Refractory Multiple Myeloma

Anupama D. Kumar, MD,Alfred Chung, MD,Darren Pan, MD,Ajai Chari, MD

View Articletitled, DREAMMing of a Better Tomorrow: Belantamab-Based Triplet Therapy for Relapsed/Refractory Multiple Myeloma

Targeting Cell Migration to Prevent Graft-Versus-Host Disease: A New Strategy

Kate A. Markey, MBBS, PhD

View Articletitled, Targeting Cell Migration to Prevent Graft-Versus-Host Disease: A New Strategy

A Mathematical Model Incorporating Molecular Data: Personalizing Transplant Decisions for Myelodysplastic Syndromes

Christine M. McMahon, MD

View Articletitled, A Mathematical Model Incorporating Molecular Data: Personalizing Transplant Decisions for Myelodysplastic Syndromes

pDCs on Patrol and in Control of Megakaryopoiesis

Bethan Psaila, MD, PhD

View Articletitled, pDCs on Patrol and in Control of Megakaryopoiesis

Haploidentical Stem Cell Transplantation Is an Acceptable Transformative Therapy for Young Adults With Sickle Cell Disease

Beatriz Caceres-Nazario, MD,Samuel Wilson, MD, MSCR

View Articletitled, Haploidentical Stem Cell Transplantation Is an Acceptable Transformative Therapy for Young Adults With Sickle Cell Disease

Vitamin A to Keep GVHD Away: Single Oral High-Dose Vitamin A Before Bone Marrow Transplant Reduces Graft-Versus-Host Disease in Pediatric and Young Adult Patients

Pooja Khandelwal, MD,Lauren Pommert, MD

View Articletitled, Vitamin A to Keep GVHD Away: Single Oral High-Dose Vitamin A Before Bone Marrow Transplant Reduces Graft-Versus-Host Disease in Pediatric and Young Adult Patients

Feature

Trainee Corner
A Career in Academia: Should I Stay or Should I Go?

Nina Shah, MD,Anita J. Kumar, MD, PhD

View Articletitled, Trainee Corner A Career in Academia: Should I Stay or Should I Go?

Then and Now
Treatment for Acute Leukemia in Older Adults: Two Decades of Remarkable Progress

Meira Yisraeli Salman, MD,Jacob M. Rowe, MD

View Articletitled, Then and Now Treatment for Acute Leukemia in Older Adults: Two Decades of Remarkable Progress

Headlines from Washington

ASH and Federal Officials Hold Town Hall on Sickle Cell Disease

View Articletitled, ASH and Federal Officials Hold Town Hall on Sickle Cell Disease

No Data Zone

Does Sustained Monocytosis Always Mean CMML? A Case of Ras-Associated Autoimmune Leukoproliferative Disorder

Daiana Gisela Rodriguez, MD,Gabriela Raquel Luque,Maria Belen Fiora,Verónica Andreoli, PhD,Ana Victoria Sanchez, MD,Ana Lisa Basquiera, MD, MSC, PhD

View Articletitled, Does Sustained Monocytosis Always Mean CMML? A Case of Ras-Associated Autoimmune Leukoproliferative Disorder

President’s Column

A Time for Gratitude

Mohandas Narla, DSc

View Articletitled, A Time for Gratitude

Cover Image

Cover Image

All Issues

Advertisement intended for health care professionals

Email alerts

Latest Issue Alert

Continuous Publishing Alert

New Journal Content Alert

Latest
Most Read

Vitamin A to Keep GVHD Away: Single Oral High-Dose Vitamin A Before Bone Marrow Transplant Reduces Graft-Versus-Host Disease in Pediatric and Young Adult Patients

Trainee Corner
A Career in Academia: Should I Stay or Should I Go?

Then and Now
Treatment for Acute Leukemia in Older Adults: Two Decades of Remarkable Progress

Does Sustained Monocytosis Always Mean CMML? A Case of Ras-Associated Autoimmune Leukoproliferative Disorder

ASH and Federal Officials Hold Town Hall on Sickle Cell Disease

Advertisement intended for health care professionals

Table of Contents

Clinical Trials Corner

An Alternative to ‘Watch and Wait’ for Newly Diagnosed Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma?

Liquid Biopsy in Diffuse Large B-Cell Lymphoma

Diffusion

Hemolysis Be Gone: Iptacopan’s Role in Paroxysmal Nocturnal Hemoglobinuria

To Drive or Park the CAR: What Is the Best Option for Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma?

Blinatumomab for B-ALL? Unraveling E1910 Trial Results for the Practicing Hematologist

DREAMMing of a Better Tomorrow: Belantamab-Based Triplet Therapy for Relapsed/Refractory Multiple Myeloma

Targeting Cell Migration to Prevent Graft-Versus-Host Disease: A New Strategy

A Mathematical Model Incorporating Molecular Data: Personalizing Transplant Decisions for Myelodysplastic Syndromes

pDCs on Patrol and in Control of Megakaryopoiesis

Haploidentical Stem Cell Transplantation Is an Acceptable Transformative Therapy for Young Adults With Sickle Cell Disease

Vitamin A to Keep GVHD Away: Single Oral High-Dose Vitamin A Before Bone Marrow Transplant Reduces Graft-Versus-Host Disease in Pediatric and Young Adult Patients

Feature

Trainee Corner
A Career in Academia: Should I Stay or Should I Go?

Then and Now
Treatment for Acute Leukemia in Older Adults: Two Decades of Remarkable Progress

Headlines from Washington

ASH and Federal Officials Hold Town Hall on Sickle Cell Disease

No Data Zone

Does Sustained Monocytosis Always Mean CMML? A Case of Ras-Associated Autoimmune Leukoproliferative Disorder

President’s Column

A Time for Gratitude

Email alerts

ASH Publications

American Society of Hematology

Issue Archive

Table of Contents

Clinical Trials Corner

Diffusion

Feature

Headlines from Washington

No Data Zone

President’s Column

Cover Image

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only